This white paper explores the emergence of a unified, cross-functional data ecosystem in clinical research, driven by innovations in automation, artificial intelligence—including GenAI and agentic AI—and advanced workflow technologies. By breaking down traditional silos, embedding AI seamlessly into data management tools, and standardizing processes, sponsors and CROs can achieve greater transparency, speed, and quality in clinical trials. The paper highlights how digitized protocols, centralized standards repositories, and continuous data refreshes empower better decision-making, risk management, and sponsor control, ultimately transforming clinical trial operations for a new era of efficiency and collaboration.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
.svg){kind=icon}
